Global Ibuprofen Market Growth 2023-2029

Global Ibuprofen Market Growth 2023-2029

Ibuprofen is an API which is used to produce ibuprofen drugs. Finished drugs ibuprofen is a nonsteroidal anti-inflammatory drug (NSAID) derivative of propionic acid used for relieving pain, helping with fever and reducing inflammation.

LPI (LP Information)' newest research report, the “Ibuprofen Industry Forecast” looks at past sales and reviews total world Ibuprofen sales in 2022, providing a comprehensive analysis by region and market sector of projected Ibuprofen sales for 2023 through 2029. With Ibuprofen sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Ibuprofen industry.

This Insight Report provides a comprehensive analysis of the global Ibuprofen landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Ibuprofen portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Ibuprofen market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Ibuprofen and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Ibuprofen.

The global Ibuprofen market size is projected to grow from US$ 91 million in 2022 to US$ 110.4 million in 2029; it is expected to grow at a CAGR of 110.4 from 2023 to 2029.

Market competition is intense. Xinhua Pharmaceutical, IOLCP, Granules Biocause, Shasun, BASF and SI Group are the leaders of in the industry, with about 81% market shares.

China is the largest supplier of Ibuprofen, with a production market share nearly 48%. India is the second largest supplier of Ibuprofen, enjoying production market share nearly 30%.

North America is the largest sales place, with a sales market share nearly 29%. Following North America, Europe is the second largest sales place with the sales market share of 26%.

The classification of Ibuprofen includes USP and EP and the sales proportion of USP Ibuprofen is about 65%.

Ibuprofen is applied in Tablet, Capsule, Suspension and Other. The most proportion of Ibuprofen is used in Tablet, and the market share is about 46%.

This report presents a comprehensive overview, market shares, and growth opportunities of Ibuprofen market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:

Segmentation by type
USP
EP

Segmentation by application
Tablet
Capsule
Suspension
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Xinhua Pharmaceutical
IOLCP
Granules Biocause
Strides Shasun
BASF
SI Group
Xinhua-Perrigo Pharmaceutical
Hisoar

Key Questions Addressed in this Report

What is the 10-year outlook for the global Ibuprofen market?

What factors are driving Ibuprofen market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Ibuprofen market opportunities vary by end market size?

How does Ibuprofen break out type, application?

What are the influences of COVID-19 and Russia-Ukraine war?

Please note: The report will take approximately 2 business days to prepare and deliver.